Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.21.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Common Stock
Additional Paid-in Capital
Subscription Receivable
Accumulated Deficit
Series Seed Preferred Stock
Series A convertible preferred stock
Series A-2 convertible preferred stock
Series A-3 convertible preferred stock
Series CF convertible preferred stock
Series B convertible preferred stock
Total
Beginning balance (in share) at Dec. 31, 2019 664,167       20,714,518 5,654,072 5,932,742 8,223,036 126,641    
Beginning balance at Dec. 31, 2019 $ 66 $ 15,486,050 $ (22,677) $ (22,617,702) $ 2,071 $ 565 $ 593 $ 823 $ 12   $ (7,150,199)
Issuance of Series A-3 preferred stock (in shares)               809,294      
Issuance of Series A-3 preferred stock   428,845 (117,614)         $ 81     311,312
Issuance of Series B preferred stock (in shares)                   20,754,717  
Issuance of Series B preferred stock   10,997,925               $ 2,075 11,000,000
Offering costs   (31,690)                 (31,690)
Fair value of warrant issuances - venture debt   58,421                 58,421
Stock-based compensation   49,932                 49,932
Net loss       (1,906,527)             (1,906,527)
Ending balance at Mar. 31, 2020 $ 66 26,989,483 (140,291) (24,524,229) $ 2,071 $ 565 $ 593 $ 904 $ 12 $ 2,075 2,331,249
Ending balance (in share) at Mar. 31, 2020 664,167       20,714,518 5,654,072 5,932,742 9,032,330 126,641 20,754,717  
Beginning balance (in share) at Dec. 31, 2019 664,167       20,714,518 5,654,072 5,932,742 8,223,036 126,641    
Beginning balance at Dec. 31, 2019 $ 66 15,486,050 (22,677) (22,617,702) $ 2,071 $ 565 $ 593 $ 823 $ 12   (7,150,199)
Net loss                     (4,174,124)
Ending balance at Jun. 30, 2020 $ 66 27,325,862 (13,454) (26,791,826) $ 2,071 $ 565 $ 593 $ 904 $ 83 $ 2,075 526,939
Ending balance (in share) at Jun. 30, 2020 664,167       20,714,518 5,654,072 5,932,742 9,032,330 836,331 20,754,717  
Beginning balance (in share) at Mar. 31, 2020 664,167       20,714,518 5,654,072 5,932,742 9,032,330 126,641 20,754,717  
Beginning balance at Mar. 31, 2020 $ 66 26,989,483 (140,291) (24,524,229) $ 2,071 $ 565 $ 593 $ 904 $ 12 $ 2,075 2,331,249
Issuance of Series CF preferred stock (in shares)                 709,690    
Issuance of Series CF preferred stock   286,447             $ 71   286,518
Issuance of Series A-3 preferred stock     126,837               126,837
Stock-based compensation   49,932                 49,932
Net loss       (2,267,597)             (2,267,597)
Ending balance at Jun. 30, 2020 $ 66 27,325,862 $ (13,454) (26,791,826) $ 2,071 $ 565 $ 593 $ 904 $ 83 $ 2,075 526,939
Ending balance (in share) at Jun. 30, 2020 664,167       20,714,518 5,654,072 5,932,742 9,032,330 836,331 20,754,717  
Beginning balance (in share) at Dec. 31, 2020 664,167       20,714,518 5,654,072 5,932,742 9,032,330 836,331 20,754,717  
Beginning balance at Dec. 31, 2020 $ 66 27,481,995   (33,345,997) $ 2,071 $ 565 $ 593 $ 904 $ 83 $ 2,075 (5,857,645)
Stock-based compensation   36,976                 36,976
Net loss       (3,023,935)             (3,023,935)
Ending balance at Mar. 31, 2021 $ 66 27,518,971   (36,369,932) $ 2,071 $ 565 $ 593 $ 904 $ 83 $ 2,075 (8,844,604)
Ending balance (in share) at Mar. 31, 2021 664,167       20,714,518 5,654,072 5,932,742 9,032,330 836,331 20,754,717  
Beginning balance (in share) at Dec. 31, 2020 664,167       20,714,518 5,654,072 5,932,742 9,032,330 836,331 20,754,717  
Beginning balance at Dec. 31, 2020 $ 66 27,481,995   (33,345,997) $ 2,071 $ 565 $ 593 $ 904 $ 83 $ 2,075 (5,857,645)
Issuance of Series A-3 preferred stock (in shares)               809,294 709,690    
Conversion of preferred stock into common stock                     6,293
Conversion of debt into common stock                     2,680,289
Conversion of related party notes and payables into common stock                     257,515
Net loss                     (13,721,433)
Ending balance at Jun. 30, 2021 $ 1,104 51,939,819   (47,067,430)             4,873,493
Ending balance (in share) at Jun. 30, 2021 11,044,594                    
Beginning balance (in share) at Mar. 31, 2021 664,167       20,714,518 5,654,072 5,932,742 9,032,330 836,331 20,754,717  
Beginning balance at Mar. 31, 2021 $ 66 27,518,971   (36,369,932) $ 2,071 $ 565 $ 593 $ 904 $ 83 $ 2,075 (8,844,604)
Conversion of preferred stock into common stock $ 403 5,888     $ (2,071) $ (565) $ (593) $ (904) $ (83) $ (2,075)  
Conversion of preferred stock into common stock (shares) 4,027,181       (20,714,518) (5,654,072) (5,932,742) (9,032,330) (836,331) (20,754,717)  
Issuance of common stock in public offering $ 241 9,999,761                 10,000,002
Issuance of common stock in public offering (in shares) 2,409,639                    
Offering costs   (2,116,957)                 (2,116,957)
Exercise of over-allotment option $ 36 1,364,961                 1,364,997
Exercise of over-allotment option (in shares) 361,445                    
Conversion of debt into common stock $ 114 2,680,175                 2,680,289
Conversion of debt into common stock (in shares) 1,135,153                    
Conversion of related party notes and payables into common stock $ 15 257,500                 257,515
Conversion of related party notes and payables into common stock (in shares) 152,357                    
Common stock and warrants issued in connection with note $ 2 73,956                 73,958
Common stock and warrants issued in connection with note (in shares) 20,000                    
Common stock issued in connection with business combination $ 219 8,025,323                 8,025,542
Common stock issued in connection with business combination (in shares) 2,192,771                    
Exercise of warrants $ 3 145,693                 145,696
Exercise of warrants (in shares) 31,881                    
Common stock issued pursuant to consulting agreement $ 5 182,995                 183,000
Common stock issued pursuant to consulting agreement (in shares) 50,000                    
Stock-based compensation   3,801,553                 3,801,553
Net loss       (10,697,498)             (10,697,498)
Ending balance at Jun. 30, 2021 $ 1,104 $ 51,939,819   $ (47,067,430)             $ 4,873,493
Ending balance (in share) at Jun. 30, 2021 11,044,594